Angiopoietin	0	12	B-Gene_or_gene_product
/	12	13	O
tie	13	16	B-Gene_or_gene_product
-	16	17	I-Gene_or_gene_product
2	17	18	I-Gene_or_gene_product
as	19	21	O
mediators	22	31	O
of	32	34	O
angiogenesis	35	47	O
:	47	48	O
a	49	50	O
role	51	55	O
in	56	58	O
congestive	59	69	O
heart	70	75	B-Organ
failure	76	83	O
?	83	84	O

Angiogenic	86	96	O
factors	97	104	O
,	104	105	O
in	106	108	O
particular	109	119	O
vascular	120	128	B-Gene_or_gene_product
endothelial	129	140	I-Gene_or_gene_product
growth	141	147	I-Gene_or_gene_product
factor	148	154	I-Gene_or_gene_product
(	155	156	O
VEGF	156	160	B-Gene_or_gene_product
)	160	161	O
and	162	165	O
the	166	169	O
angiopoietins	170	183	B-Gene_or_gene_product
,	183	184	O
Ang	185	188	B-Gene_or_gene_product
-	188	189	I-Gene_or_gene_product
1	189	190	I-Gene_or_gene_product
and	191	194	O
-	195	196	B-Gene_or_gene_product
2	196	197	I-Gene_or_gene_product
,	197	198	O
have	199	203	O
recently	204	212	O
generated	213	222	O
significant	223	234	O
interest	235	243	O
,	243	244	O
especially	245	255	O
in	256	258	O
oncology	259	267	O
.	267	268	O

The	269	272	O
process	273	280	O
of	281	283	O
angiogenesis	284	296	O
is	297	299	O
also	300	304	O
thought	305	312	O
to	313	315	O
occur	316	321	O
in	322	324	O
response	325	333	O
to	334	336	O
ischaemic	337	346	O
conditions	347	357	O
,	357	358	O
which	359	364	O
lie	365	368	O
at	369	371	O
the	372	375	O
core	376	380	O
of	381	383	O
cardiovascular	384	398	O
disease	399	406	O
states	407	413	O
such	414	418	O
as	419	421	O
coronary	422	430	B-Multi-tissue_structure
artery	431	437	I-Multi-tissue_structure
disease	438	445	O
and	446	449	O
congestive	450	460	O
heart	461	466	B-Organ
failure	467	474	O
.	474	475	O

However	476	483	O
,	483	484	O
current	485	492	O
data	493	497	O
do	498	500	O
not	501	504	O
conclusively	505	517	O
show	518	522	O
evidence	523	531	O
of	532	534	O
angiogenesis	535	547	O
per	548	551	O
se	552	554	O
in	555	557	O
these	558	563	O
conditions	564	574	O
,	574	575	O
despite	576	583	O
(	584	585	O
for	585	588	O
example	589	596	O
)	596	597	O
the	598	601	O
presence	602	610	O
of	611	613	O
high	614	618	O
levels	619	625	O
of	626	628	O
VEGF	629	633	B-Gene_or_gene_product
and	634	637	O
Ang	638	641	B-Gene_or_gene_product
-	641	642	I-Gene_or_gene_product
2	642	643	I-Gene_or_gene_product
.	643	644	O

High	645	649	O
levels	650	656	O
of	657	659	O
these	660	665	O
angiogenic	666	676	O
factors	677	684	O
in	685	687	O
heart	688	693	B-Organ
disease	694	701	O
also	702	706	O
have	707	711	O
not	712	715	O
translated	716	726	O
into	727	731	O
clinically	732	742	O
significant	743	754	O
new	755	758	O
vessel	759	765	B-Multi-tissue_structure
formation	766	775	O
,	775	776	O
as	777	779	O
in	780	782	O
accelerated	783	794	O
cancer	795	801	B-Pathological_formation
growth	802	808	O
or	809	811	O
proliferative	812	825	O
retinopathy	826	837	O
.	837	838	O

Indeed	839	845	O
,	845	846	O
we	847	849	O
would	850	855	O
hypothesize	856	867	O
that	868	872	O
these	873	878	O
angiogenic	879	889	O
markers	890	897	O
-	897	898	O
-	898	899	O
especially	899	909	O
the	910	913	O
angiopoietins	914	927	B-Gene_or_gene_product
-	927	928	O
-	928	929	O
do	929	931	O
not	932	935	O
necessarily	936	947	O
translate	948	957	O
into	958	962	O
new	963	966	O
vessel	967	973	B-Multi-tissue_structure
formation	974	983	O
in	984	986	O
congestive	987	997	O
heart	998	1003	B-Organ
failure	1004	1011	O
(	1012	1013	O
CHF	1013	1016	O
)	1016	1017	O
,	1017	1018	O
but	1019	1022	O
may	1023	1026	O
well	1027	1031	O
reflect	1032	1039	O
disturbances	1040	1052	O
of	1053	1055	O
endothelial	1056	1067	B-Tissue
integrity	1068	1077	O
in	1078	1080	O
CHF	1081	1084	O
.	1084	1085	O

